Skip to main content
PB Global Limited logo

PB Global Limited — Investor Relations & Filings

Ticker · 506580 ISIN · INE615W01011 LEI · 9845008M5D86564DCE46 BSE.NS Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2024-02-14 Regulatory Filings
Country IN India
Listing BSE.NS 506580

About PB Global Limited

https://pbglobal.in/

PB Global Limited is an enterprise engaged in the manufacturing and distribution of a diverse range of chemical products and industrial intermediates. The company focuses on the procurement, processing, and supply of specialty chemicals, organic and inorganic intermediates, and raw materials utilized across various manufacturing sectors. Its operations encompass the sourcing of high-quality chemical components to meet the technical requirements of industrial clients. PB Global Limited emphasizes operational efficiency in its supply chain management and technical expertise in chemical handling. The company's portfolio includes products designed for applications in sectors such as agriculture, pharmaceuticals, and industrial manufacturing, providing essential inputs for complex chemical synthesis and production processes. By leveraging established distribution networks, the firm facilitates the movement of critical chemical commodities to various markets.

Recent filings

Filing Released Lang Actions
Financial results and Limited reviews
Regulatory Filings
2024-02-14 English
To consider, take on record and approve the Un-Audited Standalone and Consolidated Financial results along with Limited Review Report and Cash flow for the quarter ended 31st December, 2023;
Regulatory Filings
2024-02-14 English
PB Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve To consider, take on record and approve ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended December 31, 2023. It is addressed to the stock exchange and references compliance with SEBI regulations. The document is short (2131 characters) and serves as an intimation or announcement of an upcoming board meeting rather than containing any financial data or results itself. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general regulatory announcement under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
2024-02-05 English
Certificate under regulation 74 (5)
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018, confirming the dematerialization of physical share certificates for the quarter ended 31st December 2023. It is a compliance certification related to share dematerialization, not a financial report or announcement of financial results. The document is short (1141 characters) and serves as an official attestation rather than a report containing financial data or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2024-01-15 English
Quarterly results standalone & consolidated 30.09.2023
Regulatory Filings
2023-11-14 English
Quarterly results Standalone & Consolidated 30.09.2023
Regulatory Filings
2023-11-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.